美国500万参保患者队列中按肾功能水平划分的贫血患病率、类型及相关风险
该研究基于美国57个医疗中心2016至2019年5004957例门诊患者数据,采用横断面与前瞻性队列设计,分析按eGFR和血红蛋白水平划分的贫血患病率、危险因素及相关风险。结果显示较低eGFR与贫血患病率增加强烈相关,低血红蛋白独立关联肾脏替代治疗、心血管疾病、冠心病、卒中、心力衰竭及死亡风险增加。
要点
- 较低eGFR与贫血患病率增加强烈相关,即使校正后仍显著。
- 贫血患者中铁检查不频繁,但受检者低铁结果普遍:男性60.4%、女性81.3%。
- 低血红蛋白独立关联肾脏替代治疗、心血管疾病、冠心病、卒中、心力衰竭及死亡风险增加。
核心结论
- 严重贫血常见,与较低eGFR及多种不良结局强烈相关。
- 受检者低铁结果普遍,尽管铁检查不频繁。
- 非透析CKD患者中ESA使用不常见。
研究设计与样本
- 横断面与前瞻性队列研究,数据来自Optum Labs数据仓库,覆盖美国57个医疗中心2016至2019年5004957例门诊患者。
- 平均年龄54岁,男性占42%。
主要发现
- 较低eGFR与贫血患病率增加非常强烈相关,校正后仍显著。
- 贫血患者铁检查不频繁,但受检者低铁结果普遍:男性60.4%、女性81.3%。
- ESA使用不常见,使用率<4%。
- 较低血红蛋白独立关联肾脏替代治疗、心血管疾病、冠心病、卒中、心力衰竭及死亡风险增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 依赖ICD编码进行医学诊断。
- 死亡信息来自理赔数据。
- 观察性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Anemia is common in chronic kidney disease (CKD); although anemia is associated with adverse outcomes, the available treatments are not ideal. We characterized the burden, risk factors for, and risks associated with anemia by estimated glomerular filtration rate (eGFR) and hemoglobin level. STUDY DESIGN: Cross-sectional and prospective cohort study. SETTING & PARTICIPANTS: Outpatient data from 5,004,957 individuals across 57 health care centers in the United States from 2016 to 2019, extracted from the Optum Labs Data Warehouse. EXPOSURE: Severity of anemia, presence of low iron test results, eGFR. OUTCOME: Incident kidney failure with replacement therapy, cardiovascular disease, coronary heart disease, stroke, heart failure, death. ANALYTICAL APPROACH: The prevalences of anemia, low iron test results, vitamin B12 deficiency, and erythropoiesis-stimulating agent (ESA) use, stratified by sex and eGFR, were characterized. Polychotomous logistic regression was used to estimate the adjusted odds ratios of different hemoglobin levels across eGFR. Cox proportional hazards regression was used to calculate adjusted hazard ratios for adverse outcomes across hemoglobin level. RESULTS: The mean age was 54 years, and 42% were male. Lower eGFR was very strongly associated with increased prevalence of anemia, even after adjustment. Although iron studies were checked infrequently in patients with anemia, low iron test results were highly prevalent in those tested: 60.4% and 81.3% of men and women, respectively. ESA use was uncommon, with a prevalence of use of<4%. Lower hemoglobin was independently associated with increased risk of incident kidney failure with replacement therapy, cardiovascular disease, coronary heart disease, stroke, heart failure, and death. LIMITATIONS: Reliance on ICD codes for medical diagnoses, death information obtained from claims data, observational study. CONCLUSIONS: Severe anemia was common and strongly associated with lower eGFR and multiple adverse outcomes. Low-iron test results were highly prevalent in those tested despite iron studies being checked infrequently. ESA use in nondialysis CKD patients was uncommon.
引用
- Farrington DK, Sang Y, Grams ME, et al. Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function. Am J Kidney Dis. 2022. PMID: 36181996. doi:10.1053/j.ajkd.2022.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。